New Chair of the future Sussex Integrated Care Board starts today

Stephen Lightfoot has started today as the new Chair Designate of the future Integrated Care Board (ICB) for Sussex.

New Chair appointed for future Sussex Integrated Care Board

Stephen was appointed last month following a comprehensive recruitment process, led by NHS England and NHS Improvement and endorsed by the Secretary of State.

Stephen and his family have lived in Sussex for 27 years and he is passionate about improving the health and care of our communities.

He said:

“It is a huge honour to have been appointed as the Chair Designate of the Sussex Health and Care Partnership Integrated Care Board and I’m looking forward to working with all of our partner organisations and their incredible staff to help deliver our Sussex 2025 vision for a healthier future.”

 

Stephen will initially have a designate role, ahead of the ICB becoming fully functional from April 2022, subject to Parliament confirming the current plans.

ICBs are part of the new legislative proposals set out in the Health and Care Bill 2021, which will put the 42 Integrated Care Systems (ICSs) across the country on a statutory footing, empowering health and care organisations to work with partners to better join-up health and care, with the aim of improving population health and reducing health inequalities. The Bill is currently at Committee Stage, where it is receiving a detailed examination following its second reading.

The proposed future ICB for Sussex will oversee the commissioning, performance, financial management and transformation of the local NHS, as part of the Sussex Health and Care Partnership ICS.

A key element of preparing for implementation of the new legislation is the recruitment of the most senior leadership roles within each ICB, starting with the ICB Chair Designate. The next step is to recruit ICB Chief Executive Officer Designates for all ICBs and this process is well advanced, with those individuals expected to be announced later this month.

In addition to the designate Chair role, Stephen is also Chair of the Medicines and Healthcare products Regulatory Agency (MHRA) and has recently completed his eight-year term as Deputy Chair of Sussex Community NHS Foundation Trust and his term as Non-Executive Chair of Sussex Primary Care Limited. Prior to his non-executive roles, Stephen had a 30-year career in the life sciences industry working on the development, manufacture and commercialisation of medicines and medical devices in a wide range of therapy areas for UK and global healthcare companies.